Alterity Therapeutics Ltd Adr (ATHE)

Nov 15, 2024

Opthea adds Kathy Connell to Board of Directors - Investing.com

Nov 15, 2024

Oct 15, 2024

Alterity Therapeutics to join Maxim Healthcare Summit - Investing.com

Oct 15, 2024

Oct 14, 2024

Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.

Oct 14, 2024

Oct 04, 2024

Alterity Therapeutics announces change in share registry - Investing.com

Oct 04, 2024

Oct 04, 2024

Alterity Therapeutics announces change in share registry By Investing.com - Investing.com UK

Oct 04, 2024

Oct 01, 2024

Opthea Ltd stock soars to 52-week high, hits $4.47 - Investing.com India

Oct 01, 2024

Oct 01, 2024

Alterity Therapeutics names new CFO - Investing.com India

Oct 01, 2024

Sep 26, 2024

Alterity Therapeutics discloses annual report for 2024 - Investing.com

Sep 26, 2024

Jul 19, 2024

Alterity Therapeutics announces regulatory notice filing - Investing.com

Jul 19, 2024

Jul 18, 2024

ATHE’s Stock Market Adventure: -14.26% YTD Growth Amidst Volatility - The InvestChronicle

Jul 18, 2024

Jul 17, 2024

Alterity reports positive Phase 2 trial interim data - Investing.com

Jul 17, 2024

Jul 15, 2024

Alterity Therapeutics announces trading halt - Investing.com

Jul 15, 2024

Jul 15, 2024

Alphabet stock cited by TD Cowen amid potential Wiz acquisition - Investing.com

Jul 15, 2024

Jul 15, 2024

Alterity Therapeutics announces trading halt By Investing.com - Investing.com

Jul 15, 2024

Jul 15, 2024

Avenue Supermarts stock target raised by Nuvama, still a Hold - Investing.com India

Jul 15, 2024

Jul 15, 2024

Wolfe Research keeps Peerperform rating on Goldman Sachs stock, notes mixed Q2 earnings - Investing.com India

Jul 15, 2024

Jun 17, 2024

RBC Capital sees growth potential in Bowhead Specialty shares - Investing.com

Jun 17, 2024

Jun 12, 2024

ATHEAlterity Therapeutics Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Jun 12, 2024

Apr 26, 2024

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners - Stockhead

Apr 26, 2024

Feb 15, 2024

Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners - Stockhead

Feb 15, 2024

Jan 02, 2024

ASX Health Winners December: Health stocks beat market, look ‘undervalued’ going into 2024 - Stockhead

Jan 02, 2024

Nov 20, 2023

Closing Bell: The ASX is slightly higher, but not much cooler on Monday - Stockhead

Nov 20, 2023

Aug 17, 2023

Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money ... - Stockhead

Aug 17, 2023

Jan 06, 2023

Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation) - PR Newswire

Jan 06, 2023

Mar 19, 2020

The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance

Mar 19, 2020

Mar 17, 2020

The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Sh - Benzinga

Mar 17, 2020

Jan 12, 2020

Check up: Enthusiasm rather than news is moving health stocks - Stockhead

Jan 12, 2020

Jan 03, 2020

The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger - Yahoo Finance

Jan 03, 2020

Dec 19, 2019

The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For An - Benzinga

Dec 19, 2019

Jul 30, 2019

54 Biggest Movers From YesterdayAcasti Pharma (NASDAQ:ACST), Alterity Therapeutics (NASDAQ:ATHE) - Benzinga

Jul 30, 2019